The molecular basis of antithrombin deficiency in Belgian and Dutch families.
The molecular basis of hereditary antithrombin (AT) deficiency has been investigated in ten Belgian and three Dutch unrelated kindreds. Eleven of these families had a quantitative or type I AT deficiency, with a history of major venous thromboembolic events in different affected members. In the other two families a qualitative or type II AT deficiency was occasionally diagnosed. DNA studies of the AT gene were performed, using polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis, followed by direct sequencing of the seven exons and intron-exon junction regions. Six novel point mutations were identified: four missense, one nonsense mutation and a single nucleotide deletion near the reactive site, causing a frameshift with premature translation termination. In two kindreds the underlying genetic defect was caused by a whole gene deletion, known as a rare cause of AT deficiency. In these cases, Southern blot and polymorphism analysis of different parts of the AT gene proved useful for diagnosis. In another kindred a partial gene deletion spanning 698 basepairs could precisely be determined to a part of intron 3B and exon 4. In two type I and in both type II AT deficient families a previously reported mutation was identified. In all cases, the affected individuals were heterozygous for the genetic defect.
Jochmans
K
K
Department of Hematology, Academic Hospital Free University Brussels, Belgium.
Lissens
W
W
Seneca
S
S
Capel
P
P
Chatelain
B
B
Meeus
P
P
Osselaer
J C
JC
Peerlinck
K
K
Seghers
J
J
Slacmeulder
M
M
Stibbe
J
J
van de Loo
J
J
Vermylen
J
J
Liebaers
I
I
De Waele
M
M
D000293:Adolescent; D000328:Adult; D000991:Antithrombins / Q000172:deficiency* / Q000235:genetics*; D001530:Belgium; D002648:Child; D005260:Female; D016368:Frameshift Mutation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D017354:Point Mutation
D000991:Antithrombins